Craig A. Collard, Chief Executive Officer at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 150,000 shares at $0.92 ($138K) on 2023-11-16, disclosed to the SEC on 2023-11-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| OPNT | BUY | 2022-05-16 | $39K | — | Filing → |
| SRRA | BUY | 2021-11-24 | $622K | — | Filing → |
| OPNT | BUY | 2021-09-15 | $45K | — | Filing → |